Back to Results
First PageMeta Content
EDRN / Biotechnology / Biomarker / PCA3 / Validation / Imaging biomarker / Biology / Medicine / Science


National Cancer Institute Early Detection Research Network (EDRN) A National Infrastructure for Biomarker Development
Add to Reading List

Document Date: 2014-06-26 11:25:30


Open Document

File Size: 738,75 KB

Share Result on Facebook

City

Cancer ResearchUK / /

Company

Beckman Coulter / International Partnerships / Effective / Lustgarten Inc. / Biomarker Reference Labs / Jet Propulsion Laboratory / Leveraging Resources / Associate Members (more than 200) Strategic Partnerships / Canary Inc. / Biomarker Development Labs / Scientific Advisors June / Pacific Northwest National Laboratory / M.P.H. / /

Country

Turkey / Japan / China / Israel / Chile / /

Event

FDA Phase / Company Expansion / /

Facility

National Institute of Standards and Technology / /

IndustryTerm

Cancer Prevention / integrated infrastructure / active protocols / project management / /

MedicalCondition

Ovarian Cancer / disease / mesothelioma / Liver Cancer / Prostate Cancer / /

OperatingSystem

L3 / /

Organization

Biomarker Development NCI Board of Scientific / National Institute of Standards and Technology / EDRN Discovery BDL Biomarker Development Lab / With Canary Foundation / Cancer Prevention U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health EDRN Program Objectives / Lustgarten Foundations / Data Management and Coordinating Center / FDA / National Aeronautics and Space Administration / Organization of EDRN Discovery Validation Informs Discovery Assay Development Validation Biomarker Triage System / Canary Foundation of America / European Union / Center for Prostate Disease Research / Department of Defense / /

Person

Barry Kramer / Margaret Sullivan Pepe / /

Position

Director / Division / /

Product

OVA1 / Liver Cancer / Prostate Cancer / /

Technology

Diagnostic Tests / 200 active protocols / /

URL

www.eatris.eu / /

SocialTag